(11beta)-21-Acetoxy-11-hydroxy-3,20-dioxopregna-1,4-dien-17-yl valerate(CAS: 72064-79-0)

(11beta)-21-Acetoxy-11-hydroxy-3,20-dioxopregna-1,4-dien-17-yl valerate is a solid with a crystalline form. Its molecular weight is approximately 484.5 g/mol. The compound has limited water solubility and is highly reactive towards nucleophiles. It is susceptible to hydrolysis and oxidation under basic and acidic conditions, respectively.

(11beta)-21-Acetoxy-11-hydroxy-3,20-dioxopregna-1,4-dien-17-yl valerate is synthesized via a multi-step process involving acetylation, hydroxylation, and esterification. This process requires specific catalysts and conditions to achieve high yield and selectivity. Commonly, the synthesis involves starting materials such as progesterone and acetic anhydride under controlled laboratory conditions.

(11beta)-21-Acetoxy-11-hydroxy-3,20-dioxopregna-1,4-dien-17-yl valerate is primarily used in the pharmaceutical industry as an intermediate in drug synthesis. It may also have applications in research and development for various purposes including but not limited to biological studies and chemical synthesis processes.

When handling (11beta)-21-Acetoxy-11-hydroxy-3,20-dioxopregna-1,4-dien-17-yl valerate, it is important to use appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. Store the compound in a cool, dry place away from direct sunlight and heat sources. Work under a fume hood to minimize exposure to potential vapors. In case of a spill, follow standard laboratory safety protocols and refer to the Safety Data Sheet (SDS) for detailed instructions.